Company · CIK 0001862150 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Cingulate Inc. · CING
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 AForm 4 → | Jul 20, 7:37 pm EDT | Shane J. SchafferChief Executive Officer, Director | 295,000 | — | — | 97,350 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:35 pm EDT | Bryan Wade DowneyEVP & Chief Commercial Officer | 100,000 | — | — | 33,000 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:32 pm EDT | Bryan Jay LawrenceDirector | 20,000 | — | — | 20,000 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:32 pm EDT | Matthew BramsEVP and Chief Medical Officer | 80,000 | — | — | 26,400 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:29 pm EDT | Thomas Jeffrey HargrovesDirector | 20,000 | — | — | 20,000 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:29 pm EDT | Jennifer L. CallahanEVP and CFO | 60,000 | — | — | 19,800 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:27 pm EDT | Peter J. WerthDirector | 20,000 | — | — | 20,000 | — | |
| Jul 16, 2026 AForm 4 → | Jul 20, 7:27 pm EDT | Raul R. SilvaEVP and CSO | 80,000 | — | — | 26,400 | — | |
| Jun 30, 2026 AForm 4 → | Jul 2, 6:00 pm EDT | Raul R. SilvaEVP and CSO | 3,885 | — | — | 3,885 | — |